CD BioSciences Provide Genetic Testing to Support Disease Diagnosis and Predict Disease Risks

October 11 09:57 2022
CD BioSciences announced the release of its genetic testing service that can be applied to support disease diagnosis and predict disease risks.

New York, USA – October 11, 2022 – CD BioSciences, a biotechnology-based company, focuses on developing high-throughput DNA synthesis methods to synthesize DNA with high throughput, efficiency, and precision. With an experienced scientist team, CD BioSciences is capable to provide powerful methods for the DNA research of all mankind, and accelerating the development of biology. Recently, CD BioSciences announced the release of its genetic testing service that can be applied to support disease diagnosis and predict disease risks.

The genetic testing methods provided by CD BioSciences mainly include as follows:

Biochemical tests: chemical tests that measure the amount of protein in blood, urine, and amniotic fluid samples. It is used to diagnose genetic defects caused by an imbalance in a certain protein that maintains the body’s normal function.

Chromosomal analysis: Directly detects abnormalities in the number and structure of chromosomes, rather than detecting mutations or abnormalities in a gene on a chromosome. It is often used to diagnose abnormalities in the fetus.

DNA analysis: Mainly used to identify genetic diseases caused by abnormalities in a single gene, mainly by analyzing cells from blood or hair.

The application direction of genetic testing is mainly in medical care, including newborn genetic screening, non-invasive examination, early tumor screening, cardiovascular disease estimation, nucleic acid amplification testing and doctor’s medication guidance. Genetic testing offers huge advantages over traditional diagnostic methods in diagnosing the etiology of certain diseases.

For most genetic testing processes, CD BioSciences’ htDNA-chip technology platform can provide high-throughput next-generation sequencing, which greatly shortens the gene sequencing time. htDNA chips can achieve the output of sequencing results in minutes, which greatly promotes the application of genetic testing in medical care.

The participation of htDNA-chip can promote the development of genetic testing in medical diagnosis. With the participation of htDNA-chip, instant feedback can be achieved, enabling patients to obtain test results in the shortest possible time.

“We are working on the research and applications of high throughput DNA synthesis technology,” said the marketing director of CD BioSciences, she also claimed, “We are able to synthesize DNA with unprecedented accuracy, scale and customized solution.”

About CD BioSciences

CD BioSciences’ proprietary htDNA-Chip® technology platform is dedicated to synthesizing large volumes of high-throughput and high-precision DNA to meet all your research needs. CD BioSciences has always adhered to a customer-centric way of thinking. Our way of thinking is the cornerstone of our identity, position, and behavior.

Media Contact
Company Name: CD BioSciences
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-372-1052
Country: United States
Website: https://www.htdna-chip.com